News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

|Videos|April 7, 2023

Insights into the Burden of Acne and Role of Over-the-Counter Products

Author(s)Joshua Zeichner, MD

Joshua Zeichner, MD discusses the burden of acne in his patients and provides his best practices for setting and managing treatment expectations with over the counter and prescription treatment options in between sessions at AAD.

Episodes in this series

EP. 1 Insights into the Burden of Acne and Role of Over-the-Counter Products

EP. 1 Insights into the Burden of Acne and Role of Over-the-Counter Products

EP. 2 Practice Pearls for Combination Treatment with Over the Counter and Prescription Acne Medication

EP. 2 Practice Pearls for Combination Treatment with Over the Counter and Prescription Acne Medication

EP. 3 Expert Perspectives on the Role of Tinted Sunscreens and Visible Light Protection

EP. 3 Expert Perspectives on the Role of Tinted Sunscreens and Visible Light Protection

EP. 4 Sun Protection in Patients With Skin of Color

EP. 4 Sun Protection in Patients With Skin of Color

EP. 5 Insights into Gentle Cleansing and Hydrophobically-Modified Polymers

EP. 5 Insights into Gentle Cleansing and Hydrophobically-Modified Polymers

EP. 6 Efficacy of Hydrophobically-Modified Polymers and Green Cleansing Technologies

EP. 6 Efficacy of Hydrophobically-Modified Polymers and Green Cleansing Technologies

EP. 7 Expert Perspectives into Skin Renewal and Regeneration

EP. 7 Expert Perspectives into Skin Renewal and Regeneration

EP. 8 A Conversion Around Hot Topics in Skin Renewal

EP. 8 A Conversion Around Hot Topics in Skin Renewal

EP. 9 Innovative Skin Care Pearls From AAD

EP. 9 Innovative Skin Care Pearls From AAD

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

Syrian Study Confirms Isotretinoin’s Effectiveness in Acne Treatment

ByMaddi Hebebrand, MC, Associate Editor

December 2nd 2025

Q&A: Dermatologists' Critical Role in Managing Cutaneous Toxicities in Lung Cancer Therapy

ByMarie Bosslett, Assistant Editor,Mondana Ghias, MD, FAAD

December 2nd 2025

Clinical Guidance Needed as Patients Turn to Tallow for Skin Conditions

ByMaddi Hebebrand, MC, Associate Editor

December 1st 2025

Elevate-Derm Takeaways: Acne Innovation, Alopecia Care, and Cross-Specialty Insights

ByJames Canner, PA-C,Kaitlyn Bader, Assistant Managing Editor

November 25th 2025

Journal Digest: November 19, 2025

ByMarie Bosslett, Assistant Editor

November 19th 2025

Latest CME

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Joseph Gorelick, MSN, FNP-C

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Brad P. Glick, DO, MPH, FAAD

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Hilary Baldwin; Neal Bhatia, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

In-Person Event

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

June 17-19, 2026

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

Trending on Dermatology Times

Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results

Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott

Reviewing Type 2 Inflammation Through a Different Lens

Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic

Dermatology Conferences and Meetings Calendar: December 2025

© 2025 MJH Life Sciences^®

All rights reserved.